Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer
US10034860B2 · kind B2 · utility
0Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2017 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | May 8, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods of treating locally advanced or metastatic estrogen receptor positive breast cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.